DA
Danielle Antalffy UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
40
Avg Return
Past Year
Past Year
8.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
45.5%
Neutral
45.5%
Negative
9.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Communication Equipment
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $9 |
15%
upside
| 1 | -65% |
–
| 26 Feb ‘26 7 days ago |
|
|
|
Neutral
Maintained
| $400 |
8%
upside
| 1 | – |
–
| 24 Feb ‘26 9 days ago |
|
|
|
Neutral
Maintained
| $22 |
3%
downside
| 1 | – |
–
| 20 Feb ‘26 13 days ago |
|
|
|
Buy
Maintained
| $55 |
81%
upside
| 1 | -6.5% |
0
%
| 18 Feb ‘26 15 days ago |
|
|
|
Buy
Maintained
| $120 |
64%
upside
| 1 | -11% |
0
%
| 5 Feb ‘26 28 days ago |
|
|
|
Sell
Maintained
| $86 |
8%
downside
| 1 | +1.4% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $95 |
13%
upside
| 2 | – |
–
| 12 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $12 |
203%
upside
| 1 | -53% |
0
%
| 23 Dec ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $91 |
46%
upside
| 1 | -39% |
0
%
| 23 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $145 |
29%
upside
| 1 | +10% |
0
%
| 23 Dec ‘25 2 months ago |
|
|
|
Buy
Initiated
| $62 |
145%
upside
| 1 | -30% |
0
%
| 12 Dec ‘25 2 months ago |
|